Islet alone versus islet after kidney transplantation: Metabolic outcomes and islet graft survival

Transplantation

Volumn 88, Issue 6, 2009, Pages 820-825

  Deng, Shaoping ^a,b,c   Markmann, James F ^a,b   Rickels, Micheal ^a   Yeh, Heidi ^a,b   Kim, James I ^a,b   Lian, Moh Moh ^a,b   Gu, Yi ^a,c   Markmann, Eileen ^a   Palanjian, Maral ^a   Barker, Clyde F ^a   Naji, Ali ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Diabetes; Islet; Transplantation.

Indexed keywords

CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG TARGETING; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; METABOLIC REGULATION; OUTCOME ASSESSMENT; PANCREAS ISLET TRANSPLANTATION; PATIENT INFORMATION; PRIORITY JOURNAL; T CELL DEPLETION; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; GRAFT SURVIVAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOSUPPRESSION; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 70350557122     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b4bdbb     Document Type: Article

References (20)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free im-munosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Shapiro AM. Ricordi C. Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
3. Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003; 237: 741.
4. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosup-pression: Miami experience. Am J Transplant 2005; 5: 2037.
5. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
6. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
7. Kaufman DB, HeringB. Islet transplantation. In: StuartF,Abecassis M, Kaufman DB, eds. Organ transplantation, chap. 8 [ed. 4]. Landes Bio-science 2003, pp 183-204.
8. Rickels MR, Naji A, Teff KL. Acute insulin responses to glucose and arginine as predictors of beta-cell secretory capacity in human islet transplantation. Transplantation 2007; 84: 1357.
9. van de Linde P, Vd Boog PJ, Tysma OM, et al. Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin. Clin Exp Immunol 2007; 149: 56.
10. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 2007; 117: 2553.
11. Toso C, Baertschiger R, Morel P, et al. Sequential kidney/islet transplantation: Efficacy and safety assessment of a steroid-free immuno-suppression protocol. Am J Transplant 2006; 6: 1049.
12. Cure P, Pileggi A, Froud T, et al. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Transplantation 2008; 85: 801.
13. Davalli AM, Maffi P, Socci C, et al. Insights from a successful case of intrahepatic islet transplantation into a type 1 diabetic patient. J Clin Endocrinol Metab 2000; 85: 3847.
14. Smith RN, Kent SC, Nagle J, et al. Pathology of an islet transplant 2 years after transplantation: Evidence for a nonimmunological loss. Transplantation 2008; 86: 54.
15. Westermark GT, Westermakrk P, Berne C, et al. Widespread amyloid deposition in transplanted human pancreastic islets. N Engl J Med 2008; 359: 977.
16. Ranuncoli A, Cautero N, Ricordi C, et al. Islet cell transplantation: In vivo and in vitro functional assessment of nonhuman primate pancreatic islets. Cell Transplant 2000; 9: 409.
17. Blondet JJ, Carlson AM, Kobayashi T, et al. The role of total pancrea-tectomy and islet autotransplantation for chronic pancreatitis. Surg Clin North Am 2007; 87: 1477.
18. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
19. Huurman VA, Hilbrands R, Pinkse GG, et al. Cellular islet autoimmu-nity associates with clinical outcome of islet cell transplantation. PLoS ONE 2008; 3: e2435.
20. Olsson R, Carlsson PO. Better vascular engraftment and function in pancreatic islets transplanted without prior culture. Diabetologia 2005; 48: 469.